Trial intelligence / Profile preview

L-Arginine for Prevention of Cardiovascular Relapses in CAD

NCT00408577Phase 3Completed

Sponsor
IRCCS Ospedale San Raffaele
Start
Nov 2004
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of arginine in coronary artery disease (CAD), sponsored by IRCCS Ospedale San Raffaele. Started Nov 2004; status: completed.

02

Drugs

arginine
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00408577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00408577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call